Dr. Tubin, a leading radiation oncologist in Austria, specializes in stereotactic photon-based radiotherapy and particle therapy, particularly protons and carbon ions, making him a top radiation therapy specialist in Europe. He is the Director of Clinical Radiobiology and Scientific Co-Director at MedAustron Center for Particle Therapy and Research in Wiener Neustadt, Austria. His groundbreaking work on immune-mediated non-targeted effects of radiotherapy, including bystander and abscopal effects, offers hope for patients with oligometastatic and unresectable bulky tumors. Recognized for his research and clinical expertise, Dr. Tubin has received multiple international awards and leads the ESTRO focus group for innovative radiotherapy techniques. His contributions to stereotactic radiotherapy and immune-mediated cancer treatment establish him as one of the most famous oncologists in Vienna, renowned for his cutting-edge radiation oncology advancements.
Dr. Tubin, a leading radiation oncologist in Austria, specializes in stereotactic photon-based radiotherapy and particle therapy, particularly protons and carbon ions, making him a top radiation therapy specialist in Europe. He is the Director of Clinical Radiobiology and Scientific Co-Director at MedAustron Center for Particle Therapy and Research in Wiener Neustadt, Austria. His groundbreaking work on immune-mediated non-targeted effects of radiotherapy, including bystander and abscopal effects, offers hope for patients with oligometastatic and unresectable bulky tumors. Recognized for his research and clinical expertise, Dr. Tubin has received multiple international awards and leads the ESTRO focus group for innovative radiotherapy techniques. His contributions to stereotactic radiotherapy and immune-mediated cancer treatment establish him as one of the most famous oncologists in Vienna, renowned for his cutting-edge radiation oncology advancements.